Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Based in the United Kingdom, Pharmanovia is a leading pharmaceutical company specialising in the development, manufacture, and commercialisation of high-quality medicines. Founded in 2013, the company, often referred to simply as Pharmanovia, has rapidly expanded its global footprint, with significant operational presence across Europe, Asia, and the Middle East.
Pharmanovia operates within the dynamic pharmaceutical preparation manufacturing sector, focusing on optimising and extending the lifecycle of established, trusted brands. Their core offerings encompass a diverse portfolio of essential medicines across therapeutic areas including cardiovascular, neurology, endocrinology, and gastroenterology. Pharmanovia distinguishes itself through its commitment to patient access and delivering sustained value through strategic product lifecycle management.
-14 vs industry average
Pharmanovia’s score of 28 is lower than 40% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing has typical carbon intensity
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
In 2023, Pharmanovia reported total carbon emissions of approximately 15.8 million kg CO2e. This figure includes Scope 1 emissions of about 60,000 kg CO2e and Scope 3 emissions of approximately 4.5 million kg CO2e, with a significant portion attributed to purchased goods and services, which accounted for about 11.3 million kg CO2e. Notably, there is no reported data for Scope 2 emissions.
Comparatively, in 2022, Pharmanovia's total emissions were approximately 12.5 million kg CO2e, with Scope 1 emissions remaining consistent at about 60,000 kg CO2e, while Scope 2 emissions were reported at approximately 3,000 kg CO2e. Scope 3 emissions for that year totalled around 3.2 million kg CO2e.
Pharmanovia has not established specific reduction targets or initiatives as part of their climate commitments, and there are no cascading emissions data from a parent company. The organisation is focused on understanding and managing its carbon footprint, but further details on future commitments or strategies are not available at this time.
No climate goals have been disclosed for Pharmanovia yet.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more